High-Expression of Cytoplasmic Poly (A) Binding Protein 1 (PABPC1) as a Prognostic Biomarker for Early-Stage Esophageal Squamous Cell Carcinoma

References

• Wu YF, Chu SC, Chang BS, Cheng YT, Wang TF. Hematologic markers as prognostic factors in nonmetastatic esophageal cancer patients under concurrent chemoradiotherapy. Biomed Res Int. 2019;5:1–11.
   Google Scholar
• Sasaki Y, Tamura M, Koyama R, Nakagaki T, Adachi Y, Tokino T. Genomic characterization of esophageal squamous cell carcinoma: insights from next-generation sequencing. World J Gastroenterol. 2016;22(7):2284–2293. doi:10.3748/wjg.v22.i7.228426900290
   PubMed Web of Science ®Google Scholar
• Lin CH, Hung TM, Chang YC, et al. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Cancers. 2020;12(3):607. doi:10.3390/cancers12030607
   PubMed Web of Science ®Google Scholar
• Tong YS, Wang XW, Zhou XL, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14:3. doi:10.1186/1476-4598-14-325608466
   PubMed Web of Science ®Google Scholar
• Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 2015;149(7):1700–1715. doi:10.1053/j.gastro.2015.08.05426376349
   PubMed Web of Science ®Google Scholar
• Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol. 2008;28(2):772–783. doi:10.1128/MCB.02078-0618039850
   PubMed Web of Science ®Google Scholar
• Kini HK, Silverman IM, Ji X, Gregory BD, Liebhaber SA. Cytoplasmic poly(A) binding protein-1 binds to genomically encoded sequences within mammalian mRNAs. RNA. 2016;22(1):61. doi:10.1261/rna.053447.11526554031
   PubMed Web of Science ®Google Scholar
• Chorghade S, Seimetz J, Emmons R, et al. Poly(A) tail length regulates PABPC1 expression to tune translation in the heart. eLife. 2017;6:e24139. doi:10.7554/eLife.2413928653618
   PubMed Web of Science ®Google Scholar
• Gray NK, Hrabálková L, Scanlon JP, Smith RW. Poly(A)-binding proteins and mRNA localization: who rules the roost? Biochem Soc Trans. 2015;43(6):1277–1284. doi:10.1042/BST2015017126614673
   PubMed Web of Science ®Google Scholar
• Peixeiro I, Â I, Barbosa C, Silva AL, Liebhaber SA, Romão L. Interaction of PABPC1 with the translation initiation complex is critical to the NMD resistance of AUG-proximal nonsense mutations. Nucleic Acids Res. 2012;40(3):1160–1173. doi:10.1093/nar/gkr82021989405
   PubMed Web of Science ®Google Scholar
• Zhu J, Ding H, Wang X, Lu Q. PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c. Int J Clin Exp Pathol. 2015;8(4):3794–3802.26097561
   PubMed Web of Science ®Google Scholar
• Zhang H, Sheng C, Yin Y, et al. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma. Cancer Lett. 2015;367(1):49–57. doi:10.1016/j.canlet.2015.07.01026188282
   PubMed Web of Science ®Google Scholar
• Takashima N, Ishiguro H, Kuwabara Y, et al. Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival. Oncol Rep. 2006;15(3):667–671.16465428
   PubMed Web of Science ®Google Scholar
• Sasagawa H, Shiozaki A, Iitaka D, et al. Ki-67 labeling index as an independent prognostic factor in human esophageal squamous cell carcinoma. Esophagus. 2012;9:195–202. doi:10.1007/s10388-012-0336-6
   Web of Science ®Google Scholar
• Taghavi N, Biramijamal F, Sotoudeh M, et al. Association of p53/p21 expression with cigarette smoking and prognosis in esophagealsquamous cell carcinoma patients. World J Gastroenterol. 2010;16(39):4958. doi:10.3748/wjg.v16.i39.495820954283
   PubMed Web of Science ®Google Scholar
• Indinnimeo M, Cicchini C, Stazi A, et al. nm23-H1 protein expression in anal canal carcinoma: does it correlate with prognosis? J Surg Oncol. 2000;74(2):163–166. doi:10.1002/1096-9098(200006)74:2<163::AID-JSO16>3.0.CO;2-D10914829
   PubMed Web of Science ®Google Scholar
• Cragle CE, MacNicol MC, Byrum SD, et al. Musashi interaction with poly(A)-binding protein is required for activation of target mRNA translation. J Biol Chem. 2019;294(28):10969–10986. doi:10.1074/jbc.RA119.00722031152063
   PubMed Web of Science ®Google Scholar
• Sun XM, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma. 2018;127(2):175–186. doi:10.1007/s00412-018-0659-829322240
   PubMed Web of Science ®Google Scholar
• Heayn M, Skvarca LB, Zhu L, et al. Impact of Ki-67 labeling index on prognostic significance of the chemotherapy response score in women with tubo-ovarian cancer treated with neoadjuvant chemotherapy. Int J Gynecol Pathol. 2021;40(3):278–285. doi:10.1097/PGP.000000000000070632897953
   PubMed Web of Science ®Google Scholar
• Giurgea LN, Ungureanu C, Mihailovici MS. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors. Rom J Morphol Embryo. 2012;53(4):967.
   PubMed Web of Science ®Google Scholar
• Kawakubo H, Ozawa S, Ando N, et al. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. Oncol Rep. 2005;14(6):1453–1459.16273238
   PubMed Web of Science ®Google Scholar
• Chen M, Huang J, Zhu Z, Zhang J, Li K. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. BMC Cancer. 2013;13:539. doi:10.1186/1471-2407-13-53924206575
   PubMed Web of Science ®Google Scholar
• Saeki H, Ohno S, Miyazaki M, et al. p53 protein accumulation in multiple oesophageal squamous cell carcinoma: relationship to risk factors. Oncology. 2002;62(2):175–179. doi:10.1159/00004826411914604
   PubMed Web of Science ®Google Scholar
• Taghavi N, Biramijamal F, Sotoudeh M, et al. p16 INK4a hypermethylation and p53, p16 and MDM2 protein expression in Esophageal Squamous Cell Carcinoma. BMC Cancer. 2010;10(1):138. doi:10.1186/1471-2407-10-13820388212
   PubMed Web of Science ®Google Scholar
• Ye J, Zhang L, Li Z, et al. High expression of MDM2 and the p53 protein is predictive biomarkers for poor prognosis of oesophageal squamous cell carcinoma. Cancer Manag Res. 2021;13:2733–2744. doi:10.2147/CMAR.S28032633790647
   PubMed Web of Science ®Google Scholar
• Khan I, Steeg PS, The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities. Oncotarget. 2018;12:10185–10202. doi:10.18632/oncotarget.2379629535799
   PubMedGoogle Scholar
• Guo XQ, Li XY. The expression and clinical significance of metastasis suppressor gene and matrix metalloproteinase-2 in esophageal squamous cell of carcinoma. Pak J Pharm Sci. 2016;29(4 Suppl):1339.27592483
   PubMed Web of Science ®Google Scholar
• Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer. 2003;4(1):51–62. doi:10.3816/CBC.2003.n.01212744759
   PubMedGoogle Scholar
• Zhang B, Zhang C, Yang X, et al. Cytoplasmic collagen XIαI as a prognostic biomarker in esophageal squamous cell carcinoma. Cancer Biol Ther. 2018;19(5):364–372. doi:10.1080/15384047.2018.142391529333916
   PubMed Web of Science ®Google Scholar